Literature DB >> 8290962

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Z Zou1, A Anisowicz, M J Hendrix, A Thor, M Neveu, S Sheng, K Rafidi, E Seftor, R Sager.   

Abstract

A gene encoding a protein related to the serpin family of protease inhibitors was identified as a candidate tumor suppressor gene that may play a role in human breast cancer. The gene product, called maspin, is expressed in normal mammary epithelial cells but not in most mammary carcinoma cell lines. Transfection of MDA-MB-435 mammary carcinoma cells with the maspin gene did not alter the cells' growth properties in vitro, but reduced the cells' ability to induce tumors and metastasize in nude mice and to invade through a basement membrane matrix in vitro. Analysis of human breast cancer specimens revealed that loss of maspin expression occurred most frequently in advanced cancers. These results support the hypothesis that maspin functions as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8290962     DOI: 10.1126/science.8290962

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  238 in total

1.  Analysis of mechanisms underlying BRMS1 suppression of metastasis.

Authors:  R S Samant; M J Seraj; M M Saunders; T S Sakamaki; L A Shevde; J F Harms; T O Leonard; S F Goldberg; L Budgeon; W J Meehan; C R Winter; N D Christensen; M F Verderame; H J Donahue; D R Welch
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 2.  Stem cells in the human breast.

Authors:  Ole William Petersen; Kornelia Polyak
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05       Impact factor: 10.005

Review 3.  Role of TLR2-dependent inflammation in metastatic progression.

Authors:  Sunhwa Kim; Michael Karin
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

4.  mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility.

Authors:  M Zhang; S Sheng; N Maass; R Sager
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

5.  S-glutathionylated serine proteinase inhibitors as plasma biomarkers in assessing response to redox-modulating drugs.

Authors:  Christina L Grek; Danyelle M Townsend; Joachim D Uys; Yefim Manevich; Woodrow J Coker; Christopher J Pazoles; Kenneth D Tew
Journal:  Cancer Res       Date:  2012-03-08       Impact factor: 12.701

Review 6.  Modeling tissue-specific signaling and organ function in three dimensions.

Authors:  Karen L Schmeichel; Mina J Bissell
Journal:  J Cell Sci       Date:  2003-06-15       Impact factor: 5.285

7.  Identification and confirmation of a module of coexpressed genes.

Authors:  H Garrett R Thompson; Joseph W Harris; Barbara J Wold; Stephen R Quake; James P Brody
Journal:  Genome Res       Date:  2002-10       Impact factor: 9.043

8.  Aberrant methylation of the maspin promoter is an early event in human breast cancer.

Authors:  Bernard W Futscher; Megan M O'Meara; Christina J Kim; Margaret A Rennels; Di Lu; Lynn M Gruman; Richard E B Seftor; Mary J C Hendrix; Frederick E Domann
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

Review 9.  Inhibition of angiogenesis: a new function for angiotensinogen and des(angiotensin I)angiotensinogen.

Authors:  Pierre Corvol; Noel Lamandé; Amauri Cruz; Jerome Celerier; Jean-Marie Gasc
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

10.  A versatile monoclonal antibody specific to human SERPINB5.

Authors:  Sonia S Y Teoh; Hong Wang; Gail P Risbridger; James C Whisstock; Phillip I Bird
Journal:  Hybridoma (Larchmt)       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.